-
1
-
-
34250020201
-
Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis
-
El-Serag HB, Lenhard Rudolph K. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007;132:2557-76.
-
(2007)
Gastroenterology
, vol.132
, pp. 2557-2576
-
-
El-Serag, H.B.1
Lenhard Rudolph, K.2
-
2
-
-
2342444542
-
Natural history of compensated viral cirrhosis: A prospective study on the incidence and hierarchy of major complications
-
Benvegnu L, Gios M, Boccato S, Alberti A. Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complications. Gut 2004; 53:7449.
-
(2004)
Gut
, vol.53
, pp. 7449
-
-
Benvegnu, L.1
Gios, M.2
Boccato, S.3
Alberti, A.4
-
4
-
-
47249128185
-
Trends in mortality from hepatocellular carcinoma in Europe, 1980-2004
-
Bosetti C, Levi F, Boffetta P, Lucchini F, Negri E, La Vecchia C. Trends in mortality from hepatocellular carcinoma in Europe, 1980-2004. Hepatology 2008;48:137-45.
-
(2008)
Hepatology
, vol.48
, pp. 137-145
-
-
Bosetti, C.1
Levi, F.2
Boffetta, P.3
Lucchini, F.4
Negri, E.5
la Vecchia, C.6
-
5
-
-
34547636501
-
Hepatocellular carcinoma: Trends of incidence and survival in Europe and the United States at the end of the 20th century
-
Capocaccia R, Sant M, Berrino F, Simonetti A, Santi V, Trevisani F, et al. Hepatocellular carcinoma: trends of incidence and survival in Europe and the United States at the end of the 20th century. Am J Gastroenterol 2007;102:1-10.
-
(2007)
Am J Gastroenterol
, vol.102
, pp. 1-10
-
-
Capocaccia, R.1
Sant, M.2
Berrino, F.3
Simonetti, A.4
Santi, V.5
Trevisani, F.6
-
6
-
-
7044260779
-
Environmental factors and risk for hepatocellular carcinoma
-
Yu MC, Yuan JM. Environmental factors and risk for hepatocellular carcinoma. Gastroenterology 2004;127:S72-S78.
-
(2004)
Gastroenterology
, vol.127
-
-
Yu, M.C.1
Yuan, J.M.2
-
7
-
-
0346874201
-
Screening for hepatocellular carcinoma in cirrhosis
-
Bolondi L. Screening for hepatocellular carcinoma in cirrhosis. J Hepatol 2003;39:1076-84.
-
(2003)
J Hepatol
, vol.39
, pp. 1076-1084
-
-
Bolondi, L.1
-
8
-
-
3843125293
-
Randomized controlled trial of screening for hepatocellular carcinoma
-
Zhang BH, Yang BH, Tang ZY. Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol 2004;130:417-22.
-
(2004)
J Cancer Res Clin Oncol
, vol.130
, pp. 417-422
-
-
Zhang, B.H.1
Yang, B.H.2
Tang, Z.Y.3
-
9
-
-
1842426695
-
Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance
-
Sangiovanni A, Del Ninno E, Fasani P, de Fazio C, Ronchi G, Romeo R. Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance. Gastroenterology 2004;126:1005-14.
-
(2004)
Gastroenterology
, vol.126
, pp. 1005-1014
-
-
Sangiovanni, A.1
del Ninno, E.2
Fasani, P.3
de Fazio, C.4
Ronchi, G.5
Romeo, R.6
-
10
-
-
79952231921
-
Management of hepatocellular carcinoma: An update
-
Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology 2011;53:1020-2.
-
(2011)
Hepatology
, vol.53
, pp. 1020-1022
-
-
Bruix, J.1
Sherman, M.2
-
11
-
-
77951295166
-
Treatment approach of hepatocellular carcinoma in Spain
-
Analysis of 705 patients from 62 centers
-
Varela M, Reig M, de la Mata M, Matilla A, Bustamante J, Pascual S, et al. Treatment approach of hepatocellular carcinoma in Spain. Analysis of 705 patients from 62 centers. Med Clin (Barc) 2010;134:569-76.
-
(2010)
Med Clin (Barc)
, vol.134
, pp. 569-576
-
-
Varela, M.1
Reig, M.2
de la Mata, M.3
Matilla, A.4
Bustamante, J.5
Pascual, S.6
-
12
-
-
0032879468
-
Prognosis of hepatocellular carcinoma: The BCLC staging classification
-
Llovet JM, Brú C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Seminar in Liver Disease 1999;19:329-38.
-
(1999)
Seminar in Liver Disease
, vol.19
, pp. 329-338
-
-
Llovet, J.M.1
Brú, C.2
Bruix, J.3
-
13
-
-
0036189111
-
Prognostic prediction and treatment strategy in hepatocellular carcinoma
-
Bruix J, Llovet JM. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology 2002;35:519-24.
-
(2002)
Hepatology
, vol.35
, pp. 519-524
-
-
Bruix, J.1
Llovet, J.M.2
-
14
-
-
33644909117
-
Prospective validation of the Barcelona Clinic Liver Cancer staging system
-
Cillo U, Vitale A, Grigoletto F, Farinati F, Brolese A, Zanus G, et al. Prospective validation of the Barcelona Clinic Liver Cancer staging system. J Hepatol 2006;44:723-31.
-
(2006)
J Hepatol
, vol.44
, pp. 723-731
-
-
Cillo, U.1
Vitale, A.2
Grigoletto, F.3
Farinati, F.4
Brolese, A.5
Zanus, G.6
-
15
-
-
34247853173
-
Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance
-
Trevisani F, Magini G, Santi V, Morselli-Labate AM, Cantarini M Ch, Di Nolfo MA, et al. Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance. Am J Gastroenterol 2007;102:1022-31.
-
(2007)
Am J Gastroenterol
, vol.102
, pp. 1022-1031
-
-
Trevisani, F.1
Magini, G.2
Santi, V.3
Morselli-Labate, A.M.4
Cantarini, M.C.5
Di Nolfo, M.A.6
-
16
-
-
67349112109
-
A modified TNM-based Japan Integrated Score combined with AFP level may serve as a better staging system for early-stage predominant hepatocellular carcinoma patients
-
Yen YH, Changchien CS, Wang JH, Kee KM, Hung CH, Hu TH, et al. A modified TNM-based Japan Integrated Score combined with AFP level may serve as a better staging system for early-stage predominant hepatocellular carcinoma patients. Dig Dis 2009;41:431-41.
-
(2009)
Dig Dis
, vol.41
, pp. 431-441
-
-
Yen, Y.H.1
Changchien, C.S.2
Wang, J.H.3
Kee, K.M.4
Hung, C.H.5
Hu, T.H.6
-
17
-
-
4544301860
-
High fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: Significance of hepatitis virus infection, age, p53 and α-catenin mutations
-
Peng SY, Chen WJ, Lai PL, Jeng YM, Sheu JC, Hsu HC. High fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and α-catenin mutations. Int J Cancer 2004;112:44-50.
-
(2004)
Int J Cancer
, vol.112
, pp. 44-50
-
-
Peng, S.Y.1
Chen, W.J.2
Lai, P.L.3
Jeng, Y.M.4
Sheu, J.C.5
Hsu, H.C.6
-
18
-
-
4544378286
-
Liver transplantation for hepatocellular carcinoma: Further considerations on selection criteria
-
Ravaioli M, Ercolani G, Cescon M, Vetrone G, Voci C, Grigioni WF, et al. Liver transplantation for hepatocellular carcinoma: further considerations on selection criteria. Liver Transplantation 2004;10:1195-202.
-
(2004)
Liver Transplantation
, vol.10
, pp. 1195-1202
-
-
Ravaioli, M.1
Ercolani, G.2
Cescon, M.3
Vetrone, G.4
Voci, C.5
Grigioni, W.F.6
-
19
-
-
0034856294
-
Clinical management of hepatocellular carcinoma
-
Conclusions of the Barcelona-2000 EASL Conference
-
Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, et al. clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL Conference. J Hepatol 2001;35:421-40.
-
(2001)
J Hepatol
, vol.35
, pp. 421-440
-
-
Bruix, J.1
Sherman, M.2
Llovet, J.M.3
Beaugrand, M.4
Lencioni, R.5
Burroughs, A.K.6
-
20
-
-
28844480321
-
Management of hepatocellular carcinoma
-
Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005;42:1208-36.
-
(2005)
Hepatology
, vol.42
, pp. 1208-1236
-
-
Bruix, J.1
Sherman, M.2
-
21
-
-
40349113041
-
Early-stage hepatocellular carcinoma: The high accuracy of real-time contrast-enhanced ultrasonography in the assessment of response to percutaneous tratment
-
Nicolau C, Vilana R, Bianchi L, Bru C. Early-stage hepatocellular carcinoma: the high accuracy of real-time contrast-enhanced ultrasonography in the assessment of response to percutaneous tratment. Eur Radiol 2007;17(Supl. 6):F80-F88.
-
(2007)
Eur Radiol
, vol.17
, Issue.SUPPL. 6
-
-
Nicolau, C.1
Vilana, R.2
Bianchi, L.3
Bru, C.4
-
22
-
-
77950616983
-
A metaanalysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma
-
Cabibbo G, Enea m, Attanasio M, Bruix j, Craxi A, Gammà C. A metaanalysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma. Hepatology 2010;51:1274-83.
-
(2010)
Hepatology
, vol.51
, pp. 1274-1283
-
-
Cabibbo, G.1
Enea, M.2
Attanasio, M.3
Bruix, J.4
Craxi, A.5
Gammà, C.6
-
23
-
-
0031782818
-
A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients
-
The Cancer of the Liver Italian Program (CLIP) Investigators
-
The Cancer of the Liver Italian Program (CLIP) Investigators. A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients. Hepatology 1998;28:751-5.
-
(1998)
Hepatology
, vol.28
, pp. 751-755
-
-
-
24
-
-
0032898237
-
Natural history of untreated nonsurgical hepatocellular carcinoma: Rationale for the design and evaluation of therapeutic trials
-
Llovet JM, Bustamante J, Castells A, Vilana R, Ayuso MC, Sala M, et al. Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology 1999;29:62-7.
-
(1999)
Hepatology
, vol.29
, pp. 62-67
-
-
Llovet, J.M.1
Bustamante, J.2
Castells, A.3
Vilana, R.4
Ayuso, M.C.5
Sala, M.6
-
25
-
-
0347320500
-
The critical issue of hepatocellular carcinoma prognostic classification: Which is the best tool available?
-
Cillo U, Bassanell M, Vitale A, Grigoletto A, Burra P. Fagiuoli S, et al. The critical issue of hepatocellular carcinoma prognostic classification: which is the best tool available? J Hepatol 2004;40:124-31.
-
(2004)
J Hepatol
, vol.40
, pp. 124-131
-
-
Cillo, U.1
Bassanell, M.2
Vitale, A.3
Grigoletto, A.4
Burra, P.5
Fagiuoli, S.6
-
26
-
-
16244369103
-
Prognosis of hepatocellular carcinoma: Comparison of 7 staging systems in an American cohort
-
Marrero JA, Fontana RJ, Barrat A, Askari F, Conjeevaram HS, Su GL, et al. Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort. Hepatology 2005;41:707-16.
-
(2005)
Hepatology
, vol.41
, pp. 707-716
-
-
Marrero, J.A.1
Fontana, R.J.2
Barrat, A.3
Askari, F.4
Conjeevaram, H.S.5
Su, G.L.6
-
27
-
-
34247498645
-
Validation of clinical AJCC/UICC TNM staging system for hepatocellular carcinoma: Analysis of 5,613 cases from a medical center in southern Taiwan
-
Kee K-M, Wang J-H, Lee Ch-M, Chen Ch-L, Changchien Ch-S, Hu T-H, et al. Validation of clinical AJCC/UICC TNM staging system for hepatocellular carcinoma: Analysis of 5,613 cases from a medical center in southern Taiwan. Int J Cancer 2007;120:2650-5.
-
(2007)
Int J Cancer
, vol.120
, pp. 2650-2655
-
-
Kee, K.-M.1
Wang, J.-H.2
Lee, C.-M.3
Chen, C.-L.4
Changchien, C.-S.5
Hu, T.-H.6
-
28
-
-
40349095123
-
Survival analysis of 904 patients with hepatocellular carcinoma in a hepatitis B virus-endemic area
-
Park KW, Park J-W, Choi J, Kim TH, Kim SH, Park HS, et al. Survival analysis of 904 patients with hepatocellular carcinoma in a hepatitis B virus-endemic area. J Gastroen Hepatol 2007;23:467-73.
-
(2007)
J Gastroen Hepatol
, vol.23
, pp. 467-473
-
-
Park, K.W.1
Park, J.-W.2
Choi, J.3
Kim, T.H.4
Kim, S.H.5
Park, H.S.6
-
29
-
-
40449095328
-
Analysis of 6381 hepatocellular carcinoma patients in southern Taiwan: Prognostic features, treatment outcome, and survival
-
Changchien Ch-S, Chen Ch-L, Yen Y-H, Wang J-H, Hu T-H, Lee Ch-M, et al. Analysis of 6381 hepatocellular carcinoma patients in southern Taiwan: prognostic features, treatment outcome, and survival. J Gastroenterol 2008;43:159-70.
-
(2008)
J Gastroenterol
, vol.43
, pp. 159-170
-
-
Changchien, C.-S.1
Chen, C.-L.2
Yen, Y.-H.3
Wang, J.-H.4
Hu, T.-H.5
Lee, C.-M.6
-
30
-
-
62749123476
-
Prognostic indicators in hepatocellular carcinoma: A systematic review of 72 studies
-
Tandon P, Garcia-Tsao G. Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies. Liver Int 2009;29:502-10.
-
(2009)
Liver Int
, vol.29
, pp. 502-510
-
-
Tandon, P.1
Garcia-Tsao, G.2
-
31
-
-
0035159601
-
Hepatocellular carcinoma in Central Europe: Prognostic features and survival
-
Schöinger-Hekele M, Müler C, Kutilek M, Oesterreicher C, Ferenci P, Gangl A. Hepatocellular carcinoma in Central Europe: prognostic features and survival. Gut 2001;48:103-9.
-
(2001)
Gut
, vol.48
, pp. 103-109
-
-
Schöinger-Hekele, M.1
Müler, C.2
Kutilek, M.3
Oesterreicher, C.4
Ferenci, P.5
Gangl, A.6
-
32
-
-
76049113547
-
Hepatocellular carcinoma surveillance and appropriate treatment options improve survival for patients with liver cirrhosis
-
Kuo Y-H, Lu Sh-N, Chen Ch-L, Cheng Y-F, Lin Ch-Y, Hung Ch-H, et al. Hepatocellular carcinoma surveillance and appropriate treatment options improve survival for patients with liver cirrhosis. Eur J Cancer 2010;46:744-51.
-
(2010)
Eur J Cancer
, vol.46
, pp. 744-751
-
-
Kuo, Y.-H.1
Lu, S.-N.2
Chen, C.-L.3
Cheng, Y.-F.4
Lin, C.-Y.5
Hung, C.-H.6
-
33
-
-
0036903694
-
Prognostic performance of the new classification of primary liver cancer of Japan (4th edition) for patients with hepatocellular carcinoma: A validation analysis
-
Ueno Sh, Tanabe G, Nuruki K, Hamanoue M, Komorizono Y, Oketani M, et al. Prognostic performance of the new classification of primary liver cancer of Japan (4th edition) for patients with hepatocellular carcinoma: a validation analysis. Hepatol Res 2002;24:395-403.
-
(2002)
Hepatol Res
, vol.24
, pp. 395-403
-
-
Ueno, S.1
Tanabe, G.2
Nuruki, K.3
Hamanoue, M.4
Komorizono, Y.5
Oketani, M.6
-
34
-
-
0021965806
-
Natural history of hepatocellular carcinoma and prognosis in relation to treatment
-
Study of 850 patients
-
Okuda K, Ohtsuki T, Obata H, Tomimatsu M, Okazaki N, Gasegawa H, et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer 1985;56:918-28.
-
(1985)
Cancer
, vol.56
, pp. 918-928
-
-
Okuda, K.1
Ohtsuki, T.2
Obata, H.3
Tomimatsu, M.4
Okazaki, N.5
Gasegawa, H.6
-
35
-
-
14544302673
-
Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: Comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre
-
Grieco A, Pompili M, Caminiti G, Miele L, Covino M, Alfei B, et al. Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre. Gut 2005;54:411-8.
-
(2005)
Gut
, vol.54
, pp. 411-418
-
-
Grieco, A.1
Pompili, M.2
Caminiti, G.3
Miele, L.4
Covino, M.5
Alfei, B.6
-
36
-
-
0038748320
-
Prognostic staging system for hepatocellular carcinoma (CLIP score): Its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score)
-
Kudo M, Chung H, Osaki Y. Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score). J Gastroenterol 2003;38:207-15.
-
(2003)
J Gastroenterol
, vol.38
, pp. 207-215
-
-
Kudo, M.1
Chung, H.2
Osaki, Y.3
-
37
-
-
10644225254
-
-
Kudo M, Chung H, Haji S, Osaki Y, Oka H, Seki T, et al. Validation of a new prognostic staging system for hepatocellular carcinoma: the JIS Score compared with the CLIP Score-Hepatology 2004;40:1396-405.
-
(2004)
Validation of a new prognostic staging system for hepatocellular carcinoma: The JIS Score compared with the CLIP Score-Hepatology
, vol.40
, pp. 1396-1405
-
-
Kudo, M.1
Chung, H.2
Haji, S.3
Osaki, Y.4
Oka, H.5
Seki, T.6
-
38
-
-
25644460472
-
Comparison of the usefulness of three staging systems for hepatocellular carcinoma (CLIP, BCLC, and JIS) in Japan
-
Toyoda H, Kumada T, Kiriyama S, Sone Y, Tanikawa M, Hisanaga Y, et al. Comparison of the usefulness of three staging systems for hepatocellular carcinoma (CLIP, BCLC, and JIS) in Japan. Am J Gastroenterol 2005;100:1764-71.
-
(2005)
Am J Gastroenterol
, vol.100
, pp. 1764-1771
-
-
Toyoda, H.1
Kumada, T.2
Kiriyama, S.3
Sone, Y.4
Tanikawa, M.5
Hisanaga, Y.6
-
39
-
-
33644787374
-
Diagnostic and prognostic role of α-fetoprotein in hepatocellular carcinoma: Both or Neither?
-
Farinati F, Marino D, De Giorgio M, Baldan A, Cantarini M, Cursaro C, et al. Diagnostic and prognostic role of α-fetoprotein in hepatocellular carcinoma: Both or Neither? Am J Gastroenterol 2006;101:524-32.
-
(2006)
Am J Gastroenterol
, vol.101
, pp. 524-532
-
-
Farinati, F.1
Marino, D.2
de Giorgio, M.3
Baldan, A.4
Cantarini, M.5
Cursaro, C.6
-
40
-
-
44649193817
-
Survival of patients with hepatocellular carcinoma in cirrhosis: A comparison of BCLC, CLIP and GRETCH staging systems
-
Cammà C, Di Marco V, Cabibbo G, Latteri F, Sandonato L, Parisi P, et al. Survival of patients with hepatocellular carcinoma in cirrhosis: a comparison of BCLC, CLIP and GRETCH staging systems. Aliment Pharmacol Ther 2008;28:62-75.
-
(2008)
Aliment Pharmacol Ther
, vol.28
, pp. 62-75
-
-
Cammà, C.1
Di Marco, V.2
Cabibbo, G.3
Latteri, F.4
Sandonato, L.5
Parisi, P.6
-
41
-
-
0033651369
-
Clinical characteristics and prognosis of hepatocellular carcinoma
-
Analysis based on serum alpha-fetoprotein levels
-
Tangkijvanich P, Anukulkarnkusol N, Suwangool P, Lertmaharit S, Hanvivatvong O, Kullavanijaya P, et al. Clinical characteristics and prognosis of hepatocellular carcinoma. Analysis based on serum alpha-fetoprotein levels. J Clin Gastroenterol 2000;31:302-8.
-
(2000)
J Clin Gastroenterol
, vol.31
, pp. 302-308
-
-
Tangkijvanich, P.1
Anukulkarnkusol, N.2
Suwangool, P.3
Lertmaharit, S.4
Hanvivatvong, O.5
Kullavanijaya, P.6
-
42
-
-
0027392507
-
Expression and hypomethylation of alpha-fetoprotein gene in unicentric and multicentric human hepatocellular carcinoma
-
Peng Sh-Y, Lai P-L, Chu J-Sh, Lee P-H, Tsung P-T, Chen D-Sh, et al. Expression and hypomethylation of alpha-fetoprotein gene in unicentric and multicentric human hepatocellular carcinoma. Hepatology 1993;17:35 41.
-
(1993)
Hepatology
, vol.17
, pp. 35-41
-
-
Peng, S.-Y.1
Lai, P.-L.2
Chu, J.-S.3
Lee, P.-H.4
Tsung, P.-T.5
Chen, D.-S.6
-
43
-
-
0028871580
-
Treatment of small hepatocellular carcinoma with percutaneous ethanol injection
-
Lencioni R, Bartolozzi C, Caramella D, Paolicchi A, Carrai M, Maltini G, et al. Treatment of small hepatocellular carcinoma with percutaneous ethanol injection. Cancer 1995;76:1737-46.
-
(1995)
Cancer
, vol.76
, pp. 1737-1746
-
-
Lencioni, R.1
Bartolozzi, C.2
Caramella, D.3
Paolicchi, A.4
Carrai, M.5
Maltini, G.6
-
44
-
-
33646541682
-
Proposal of a modified cancer of the liver italian program staging system based on the model for end-stage liver disease for patients with hepatocellular carcinoma undergoing loco-regional therapy
-
Huo T-I, Huang Y-H, Lin H-Ch, Wu J-Ch, Chiang J-H, Lee P-Ch, et al. Proposal of a modified cancer of the liver italian program staging system based on the model for end-stage liver disease for patients with hepatocellular carcinoma undergoing loco-regional therapy. Am J Gastroenterol 2006;101:975-82.
-
(2006)
Am J Gastroenterol
, vol.101
, pp. 975-982
-
-
Huo, T.-I.1
Huang, Y.-H.2
Lin, H.-C.3
Wu, J.-C.4
Chiang, J.-H.5
Lee, P.-C.6
|